Image guided activatable drug nanoparticles for cancer.
Apeikon develops image guided activatable treatments for brain tumours. The technology safely delivers multiple drugs across the blood brain to tumour barrier and releases the drugs only in the brain tumours. Due to the smart packaging of the drugs, it minimises adverse effects and therefore is suitable for paediatric patients.
Read more